Abstract
We analyzed the outcome of 18 children with idiopathic dilated cardiomyopathy (IDC). There was a striking female preponderance (M:F = 1:3.5) and 15 (83%) presented below the age of 2 years. Follow up for a mean duration of 3.5 years revealed complete recovery in seven (43%) and an additional three (19%) became asymptomatic. Three (19%) died and another three (19%) continued to be symptomatic but in controlled heart failure. Two were lost to follow up. Among those who improved, the majority (75%) did so in 1.5 years. Three of five patients who received periodic dobutamine infusion showed improvement in quality of life. The survivals of 94% at 1 year and 87% at 3 years are significantly better than those previously reported. This is the first such study of IDC in children from the Arab peninsula.
| Original language | English |
|---|---|
| Pages (from-to) | 125-128 |
| Number of pages | 4 |
| Journal | International Journal of Cardiology |
| Volume | 65 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Jul 1 1998 |
Fingerprint
Keywords
- Dilated cardiomyopathy
- Dobutamine infusion
- Prognosis
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
Improved prognosis of heart failure due to idiopathic dilated cardiomyopathy in children. / Venugopalan, P.; Agarwal, A. K.; Akinbami, F. O.; El Nour, I. B.; Subramanyan, R.
In: International Journal of Cardiology, Vol. 65, No. 2, 01.07.1998, p. 125-128.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Improved prognosis of heart failure due to idiopathic dilated cardiomyopathy in children
AU - Venugopalan, P.
AU - Agarwal, A. K.
AU - Akinbami, F. O.
AU - El Nour, I. B.
AU - Subramanyan, R.
PY - 1998/7/1
Y1 - 1998/7/1
N2 - We analyzed the outcome of 18 children with idiopathic dilated cardiomyopathy (IDC). There was a striking female preponderance (M:F = 1:3.5) and 15 (83%) presented below the age of 2 years. Follow up for a mean duration of 3.5 years revealed complete recovery in seven (43%) and an additional three (19%) became asymptomatic. Three (19%) died and another three (19%) continued to be symptomatic but in controlled heart failure. Two were lost to follow up. Among those who improved, the majority (75%) did so in 1.5 years. Three of five patients who received periodic dobutamine infusion showed improvement in quality of life. The survivals of 94% at 1 year and 87% at 3 years are significantly better than those previously reported. This is the first such study of IDC in children from the Arab peninsula.
AB - We analyzed the outcome of 18 children with idiopathic dilated cardiomyopathy (IDC). There was a striking female preponderance (M:F = 1:3.5) and 15 (83%) presented below the age of 2 years. Follow up for a mean duration of 3.5 years revealed complete recovery in seven (43%) and an additional three (19%) became asymptomatic. Three (19%) died and another three (19%) continued to be symptomatic but in controlled heart failure. Two were lost to follow up. Among those who improved, the majority (75%) did so in 1.5 years. Three of five patients who received periodic dobutamine infusion showed improvement in quality of life. The survivals of 94% at 1 year and 87% at 3 years are significantly better than those previously reported. This is the first such study of IDC in children from the Arab peninsula.
KW - Dilated cardiomyopathy
KW - Dobutamine infusion
KW - Prognosis
UR - http://www.scopus.com/inward/record.url?scp=17544403933&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=17544403933&partnerID=8YFLogxK
U2 - 10.1016/S0167-5273(98)00084-9
DO - 10.1016/S0167-5273(98)00084-9
M3 - Article
VL - 65
SP - 125
EP - 128
JO - International Journal of Cardiology
JF - International Journal of Cardiology
SN - 0167-5273
IS - 2
ER -